The relationship between the United States government and anything at all related to cannabis is thorny, to say the least. The loophole in cannabis’s Schedule 1 drug classification is technically what allows CBD to be “legal,” but this, too, is complicated. And the FDA has CBD in its sights. It has called CBD an “unapproved new drug,” and has gone so far as to test some CBD products that have claimed to be rich in CBD.

In February 2015, the FDA issued warnings to these seven CBD makers for selling bogus product: (FL)
CBD Life Holdings, LLC (makers of Ultra CBD) (AZ)
Hemp Oil Care (CA)
Twin Falls Bio Tech (SC)
Canna Companion (WA)
Canna Pet (WA)

Here’s why:
The FDA checked two different samples of UltraCBD from CBD Life Holdings and found that one sample contained ZERO cannabinoids of any kind, while the second had 0.2% CBD. Of all the products tested by the FDA in this query, this was the bottom of the barrel when it came to actual vs. reported CBD content.

Seven products from Hemp Oil Care in California were tested—three of the seven products tested negative for cannabinoids. Three of their Cibdex Hemp CBD Complex all had 0.3% CBD, and the Cibaderm Hemp Salve product contained no CBD but did have 0.2% cannabidiolic acid (CBDa).

Four products sold at from Natural Organic Solutions were tested, and their CBD oil extract 500 mg capsules and 21% CBD hemp oil came up negative for cannabinoids. Real CBD Extract 1500 mg capsules contained 0.5% CBD, 0.2% THC, 0.1% CBDa, and 0.03% THCa (tetrahydrocannabinolic acid). Their 26% CBD hemp oil showed 0.14% CBD, 0.45% THC, and 0.05% CBDa.

Arisi-Tol, a CBD lozenge product from Twin Falls Bio Tech that costs around a hundred bucks for a one-month supply, was tested as having 0.2% CBD.

Canna Companion’s “Size 4” capsules for pets were tested as well, and had 0.1% CBD, 0.1% THC, 0.3% CBDa, and 0.9% THCa. Canna-Pet’s Canna-Biscuits for Dogs had NO cannabinoids; Canna-Pet for Cats contained 0.5% CBD; and Canna-Pet MaxCBD Capsules for Dogs contained 2.6% CBD, 0.1% THC, and 0.1% CBC (cannabichromene).

Warnings to other CBD product manufacturers continue to be issued for mislabeling and other snake-oily tactics. You can view the FDA’s updated CBD warnings and test results HERE. When these warnings are given, companies are given 15 days to show compliance and fix their violations.

When it comes to accuracy and quality around CBD products, most cannabis and CBD experts agree that the best bet right now is a product sourced from the CBD-rich strains of hemp/cannabis that are being cultivated in states that have already passed legal-cannabis laws and allow hemp to be grown under the 2014 Farm Bill, like Colorado. These states require cannabis products to undergo independent lab testing, so a CBD product sourced from one of these areas is more likely to be exactly what it claims to be.

It’s important to keep an eye out for anything that seems vague or unprofessional. The FDA reported that some CBD manufacturers couldn’t even spell “cannabidiol” properly! A Google search of “CBD scams” will pull up far too many results. Be sure to do your research!



Please enter your comment!
Please enter your name here